The Biopharmaceutical Manufacturing Preparedness (BioMaP) Consortium is performing market research. The BioMaP-Consortium is interested in identifying consortium members, preferably Contract Development and Manufacturing Organizations (CDMOs), who have actively established (vice future planned) capabilities to perform cell culture manufacturing (at any scale) using adherent cell lines (preferably vero cells) and/or viral vectors (preferably VSV). These efforts typically include, but are not limited to, the use of roller bottles, t-flasks, cell factories (nunc style or equivalent), fixed bed reactors, and/or microcarriers for adherent cell culture operations.

Therefore, the BioMaP-Consortium is seeking consortium members with demonstrated experience in process development and Current Good Manufacturing Practice (cGMP) for the advanced development, scale up, and manufacturing of products that utilize adherent cell culture expression systems.

If your organization has the demonstrated experience, please tell us using the button below.

Please respond by April 9, 2025, at 11:59 PM ET.

For questions or assistance, contact us at BioMap-Consortium@ati.org.